AstraZeneca PLC Sees More Deals to Fill Out Pipeline

May 5, 2010 |

1 min read

Reuters -- Anglo-Swedish drugmaker AstraZeneca is aggressively meeting potential acquisition partners as it prepares for generic competition from some of its best-selling drugs.

Alliances

AstraZeneca Pharmaceuticals LP

MORE ON THIS TOPIC

Large sharp meat cleaver sticking out of a rustic wood cutting board on a grey background. 3d render.

Mergers & acquisitions

Merck Chopped $1B Off Terns’ Offer After Seeing Updated Leukemia Data

April 8, 2026

·

3 min read

·

Tristan Manalac

Podcast

Lilly’s Foundayo Nod Launches New Battle With Novo, M&A Mania Continues, Tariffs Hit Pharma

April 8, 2026

·

1 min read

·

Heather McKenzie

Yellow paper airplane flying in straight line over black labyrinth on light background, symbolizing leadership, business strategy, and innovation. 3D Rendering

Opinion

To Survive the Downturn, Biotechs Must Return to Basics

April 8, 2026

·

5 min read

·

Driscoll R. Ugarte

businesswoman drawing big fish on the wall

Mergers & acquisitions

Gilead Swallows Another Partner, Paying up to $5B for ADC Specialist Tubulis

April 7, 2026

·

2 min read

·

Heather McKenzie